EnteroBiotix company

EnteroBiotix, a privately held Scottish biotechnology company focused on using the body’s own microorganisms to prevent and treat disease, has raised £500,000 in an oversubscribed seed round of investment. The financing was led by Equity Gap and supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise.
Technology: P4 Medicine
Industry: Preventive Medicine
Headquarters: Edinburgh, Edinburgh, City of, United Kingdom
Founded Date: 2017
Employees Number: 1-10
Funding Status: Seed
Investors Number: 4
Total Funding: £2.5M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
info@enterobiotix.com
@enterobiotix?lang=en
Register and Claim Ownership